Procedure-C (Dermatolog) at Chughtai Lab

Procedure-C (Dermatolog) at Chughtai Lab

Procedure-C (Dermatolog) at Chughtai Lab represents a highly specialized category of histopathological and dermatopathological analysis designed for the microscopic evaluation of skin tissue specimens. In clinical dermatology and pathology, a precise diagnosis is the cornerstone of effective patient management. When a dermatologist or physician identifies an atypical skin lesion, a chronic inflammatory rash, or a suspected cutaneous malignancy, a tissue biopsy is performed. This tissue specimen is then referred to Chughtai Lab for specialized processing, sectioning, staining, and expert microscopic evaluation under the classification of Procedure-C (Dermatolog).

Dermatopathology is a complex subspecialty of pathology that bridges clinical dermatology with microscopic tissue analysis. The skin is the body’s largest organ, and it can manifest hundreds of different inflammatory, infectious, autoimmune, and neoplastic conditions. Procedure-C (Dermatolog) at Chughtai Lab utilizes advanced tissue-processing technology and state-of-the-art light microscopy to evaluate the cellular architecture of the epidermis, dermis, subcutaneous fat, and associated adnexal structures. By analyzing these microscopic details, consultant pathologists can differentiate between benign skin conditions and highly aggressive malignancies, such as melanoma or squamous cell carcinoma.

The diagnostic value of Procedure-C (Dermatolog) is unparalleled. It provides definitive diagnostic confirmation when clinical examination alone is insufficient. The procedure involves the meticulous examination of tissue sections stained with Hematoxylin and Eosin (H&E), which is the gold standard in histopathology. When necessary, the evaluation is supplemented with special histochemical stains or advanced immunohistochemistry (IHC) markers to identify specific cellular lineages, infectious organisms, or molecular profiles. This comprehensive diagnostic approach ensures that patients across Pakistan receive highly accurate, timely, and clinically actionable pathology reports to guide their treatment plans.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure the integrity of the dermatological specimen and the safety of the patient during the biopsy collection process. Patients should observe the following guidelines prior to undergoing a skin biopsy for Procedure-C (Dermatolog) analysis:

• Consultation and Medical History: Inform the performing clinician about all current medications, especially anticoagulants (such as aspirin, warfarin, clopidogrel, or direct oral anticoagulants) and nonsteroidal anti-inflammatory drugs (NSAIDs), which can increase the risk of bleeding at the biopsy site.
• Allergy Notification: Disclose any known allergies to local anesthetics (such as lidocaine), topical antiseptics (such as iodine or chlorhexidine), or surgical adhesives and latex.
• Hygiene: Bathe or wash the area surrounding the scheduled biopsy site thoroughly with soap and water on the day of the procedure to minimize the risk of post-procedure localized infection.
• No Fasting Required: Standard skin biopsies are performed under local anesthesia, meaning fasting is generally not required unless specifically instructed by the physician for complex excisions.
• Documentation: Bring all previous dermatological reports, clinical photographs, and relevant medical history to the clinic, as clinical correlation is vital for accurate dermatopathological interpretation.

During the Procedure

The clinical procedure consists of two distinct phases: the clinical collection of the skin specimen by the dermatologist and the subsequent laboratory processing at Chughtai Lab.

During the specimen collection phase, the patient is positioned comfortably based on the anatomical location of the lesion. The clinician cleanses the skin with an antiseptic solution and injects a local anesthetic (typically 1% or 2% lidocaine with or without epinephrine) to numb the area. Depending on the clinical indication, the clinician performs a shave biopsy, a punch biopsy, or an excisional biopsy. The patient may feel a brief stinging sensation during the anesthetic injection, but the biopsy itself is painless. Once the specimen is obtained, the wound is dressed, and the tissue is immediately placed into a vial containing 10% neutral buffered formalin to preserve the cellular structures and prevent autolysis.

The specimen is then securely transported to the histopathology department at Chughtai Lab. Upon arrival, the specimen undergoes gross examination, where a pathologist measures, describes, and documents the physical characteristics of the tissue. The specimen is processed using automated tissue processors, embedded in paraffin wax blocks, and sliced into ultra-thin sections (approximately 4 to 5 micrometers thick) using a high-precision microtome. These sections are mounted on glass slides, stained with Hematoxylin and Eosin (H&E), and evaluated under a multi-headed light microscope by a Consultant Pathologist specializing in dermatopathology. If required, special stains (such as PAS for fungal elements or Ziehl-Neelsen for mycobacteria) or immunohistochemical stains are applied to reach a definitive diagnosis.

When is a Procedure-C (Dermatolog) Performed?

Evaluation of Suspicious Skin Lesions and Moles

Physicians request a Procedure-C (Dermatolog) when a patient presents with a skin lesion, mole, or macule that exhibits atypical clinical features. This includes lesions demonstrating the classic ABCDE criteria of melanoma: asymmetry, border irregularity, color variation, diameter greater than 6mm, or evolving size and shape. Microscopic evaluation is critical to differentiate benign melanocytic nevi from dysplastic nevi or early-stage cutaneous melanoma, allowing for timely surgical intervention.

Diagnosis of Inflammatory and Autoimmune Skin Diseases

When patients present with chronic, widespread, or atypical skin rashes that do not respond to standard topical therapies, a biopsy is indicated. Conditions such as psoriasis, lichen planus, cutaneous lupus erythematosus, and various forms of eczema can have overlapping clinical presentations. Procedure-C (Dermatolog) allows pathologists to examine the specific pattern of inflammatory infiltrate, epidermal changes, and dermo-epidermal junction alterations to establish a definitive diagnosis.

Assessment of Chronic Non-Healing Ulcers

Chronic, non-healing ulcers of the skin, particularly those on the lower extremities or sun-exposed areas, require histopathological evaluation. Physicians perform a biopsy to rule out underlying malignancies like squamous cell carcinoma (Marjolin’s ulcer) or basal cell carcinoma. Additionally, the biopsy can identify specific infectious etiologies, such as cutaneous leishmaniasis, deep fungal infections, or atypical mycobacterial infections, which are prevalent in various regions.

Investigation of Blistering (Bullous) Disorders

Autoimmune blistering diseases, including pemphigus vulgaris, bullous pemphigoid, and dermatitis herpetiformis, are severe conditions that require precise histopathological classification. A skin biopsy evaluated under Procedure-C (Dermatolog) helps identify the exact level of blister formation (intraepidermal versus subepidermal) and the nature of the inflammatory cells within the blister cavity. This is crucial for initiating appropriate systemic immunosuppressive therapy.

Determination of Surgical Margins for Skin Tumors

Following the surgical excision of a confirmed skin malignancy, such as basal cell carcinoma or squamous cell carcinoma, the entire tissue specimen is submitted for Procedure-C (Dermatolog) analysis. The pathologist carefully examines the peripheral and deep surgical margins under the microscope to ensure that no tumor cells remain at the edges. Confirming clear margins is vital to minimize the risk of local recurrence and ensure complete patient recovery.

What Does a Procedure-C (Dermatolog) Detect?

Procedure-C (Dermatolog) at Chughtai Lab is capable of detecting a wide array of pathological changes, cellular abnormalities, and tissue structures. The microscopic analysis can identify:

• Basal Cell Carcinoma (BCC): The presence of nests of atypical basaloid cells showing peripheral palisading and retraction artifact from the surrounding stroma.
• Squamous Cell Carcinoma (SCC): Proliferation of atypical squamous cells invading the dermis, characterized by keratin pearls, cellular pleomorphism, and atypical mitotic figures.
• Malignant Melanoma: Proliferation of atypical melanocytes with pagetoid spread within the epidermis, dermal invasion, nests of pleomorphic cells, and lack of cellular maturation.
• Dysplastic Nevi: Melanocytic lesions showing architectural disorder, subepidermal fibroplasia, and random cytologic atypia.
• Psoriasis: Microscopic features including regular acanthosis (psoriasiform hyperplasia), parakeratosis, loss of the granular layer, and neutrophilic microabscesses (Munro’s microabscesses) in the stratum corneum.
• Lichen Planus: Characterized by a dense, band-like lymphocytic infiltrate at the dermo-epidermal junction, basal cell vacuolization, and apoptotic keratinocytes (Civatte bodies).
• Lupus Erythematosus: Showing vacuolar degeneration of the basal layer, thickening of the basement membrane, perivascular and periadnexal lymphocytic infiltrates, and follicular plugging.
• Pemphigus Vulgaris: Demonstrating intraepidermal suprabasal acantholysis leading to cleft formation, leaving a single layer of basal cells attached to the basement membrane (“tombstone” appearance).
• Bullous Pemphigoid: Showing subepidermal blister formation with a prominent infiltrate of eosinophils within the dermal papillae and blister cavity.
• Cutaneous Leishmaniasis: Identification of Leishmania tropica or major amastigotes (Leishman-Donovan bodies) within dermal macrophages, accompanied by a dense histiocytic and plasma cell infiltrate.
• Fungal Infections (Dermatophytosis): Presence of fungal hyphae and spores in the stratum corneum, highlighted by periodic acid-Schiff (PAS) or Grocott’s methenamine silver (GMS) stains.
• Actinic Keratosis: Intraepidermal atypia of keratinocytes confined to the lower layers of the epidermis, accompanied by hyperkeratosis and parakeratosis.
• Seborrheic Keratosis: Benign epidermal proliferation characterized by basaloid cells, hyperkeratosis, papillomatosis, and horn pseudocysts.
• Dermatofibroma: A benign dermal proliferation of spindle-shaped fibroblasts and myofibroblasts, often showing a “collagen trapping” pattern at the periphery.
• Leukocytoclastic Vasculitis: Inflammation of small dermal blood vessels characterized by fibrinoid necrosis of vessel walls, neutrophilic infiltration, and nuclear debris (karyorrhexis).
• Granuloma Annulare: Necrobiotic collagen surrounded by a palisade of histiocytes and lymphocytes, often with mucin deposition.
• Sarcoidosis: Non-caseating, “naked” epithelioid granulomas in the dermis with a sparse surrounding lymphocytic rim.
• Erythema Nodosum: A septal panniculitis showing inflammation of the fibrous septa between fat lobules, with neutrophils, histiocytes, and multinucleated giant cells.
• Alopecia Areata: Peribulbar lymphocytic infiltrate (“swarm of bees” appearance) affecting anagen hair follicles, leading to follicular regression.
• Scabies: Microscopic identification of Sarcoptes scabiei mites, eggs, or scybala within the stratum corneum of the epidermis.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to delivering highly accurate diagnostic reports within an optimal timeframe. For Procedure-C (Dermatolog), which involves complex histopathological processing, embedding, sectioning, and microscopic evaluation, the standard turnaround time is typically 3 to 5 working days. This timeline may vary if specialized immunohistochemical (IHC) stains or deeper sections are required to reach a definitive diagnosis.

Patients and referring physicians can access diagnostic reports conveniently through multiple digital channels. Chughtai Lab offers an online patient portal on their official website, where reports can be viewed and downloaded using the patient’s lab ID and password. Additionally, reports are accessible via the Chughtai Lab Mobile App, available on iOS and Android platforms. Patients also receive an SMS notification with a direct link to download their report as soon as it is finalized and signed off by the Consultant Pathologist. Physical copies of the reports can be collected from any Chughtai Lab collection center nationwide.

Procedure-C (Dermatolog) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Epidermal Architecture	Intact, normal thickness, orderly maturation of keratinocytes.	Acanthosis, hyperkeratosis, atrophy, intraepidermal atypia, or ulceration.
Melanocytic Activity	Normal distribution of basal melanocytes without nesting or atypia.	Atypical melanocytic proliferation, pagetoid spread, or dermal nesting (melanoma).
Dermal Infiltrate	Minimal or absent inflammatory cells in the dermis.	Dense perivascular, lichenoid, nodular, or diffuse inflammatory infiltrates.
Dermal Connective Tissue	Normal collagen bundles and elastic fibers.	Solar elastosis, dermal fibrosis, mucin deposition, or necrobiotic collagen.
Surgical Margins	Free of tumor cells (negative margins in excision specimens).	Involved margins (positive margins) with residual neoplastic cells.
Vascularity	Normal dermal capillaries without inflammation or thrombosis.	Fibrinoid necrosis, leukocytoclastic vasculitis, or endothelial proliferation.
Adnexal Structures	Normal hair follicles, sebaceous glands, and eccrine glands.	Destruction of adnexa, perifollicular inflammation, or follicular mucinosis.
Infectious Agents	No fungal hyphae, viral inclusions, or bacteria identified.	Presence of PAS-positive hyphae, viral cytopathic effects, or acid-fast bacilli.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Procedure-C (Dermatolog)?

• Experienced Healthcare Professionals: Chughtai Lab features a dedicated team of highly qualified Consultant Pathologists and Dermatopathologists with extensive experience in diagnosing complex skin disorders.
• Patient-Focused Care: The laboratory prioritizes patient comfort, safety, and clear communication throughout the diagnostic journey.
• Quality Diagnostic Services: Operating under strict quality control protocols, Chughtai Lab ensures high-precision tissue processing and staining.
• Professional Reporting: Reports are detailed, comprehensive, and structured to provide referring dermatologists with clear, actionable diagnostic information.
• Modern Diagnostic Approach: The histopathology department is equipped with advanced automated tissue processors, microtomes, and high-resolution microscopes.
• Comfortable Environment: All collection centers and main laboratories maintain a clean, professional, and patient-friendly environment.
• Convenient Location: With an extensive network of hundreds of collection centers across Pakistan, patients can easily submit specimens or collect reports.
• Commitment to Accurate Diagnosis: Chughtai Lab participates in external quality assurance programs to maintain international standards of diagnostic accuracy.